These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 538065)

  • 21. Regulation of hepatic cholesterol biosynthesis by clofibrate administration.
    White LW
    J Pharmacol Exp Ther; 1971 Aug; 178(2):361-70. PubMed ID: 5570460
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of clofibrate on plasma lipids of rat and rabbit.
    Byers SO; Friedman M
    Atherosclerosis; 1970; 11(3):373-82. PubMed ID: 5433083
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of chlorophenoxyisobutyrate on the synthesis and metabolism of cholesterol in man.
    Sodhi HS; Kudchodkar BJ; Horlick L; Weder CH
    Metabolism; 1971 Apr; 20(4):348-59. PubMed ID: 5550302
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of policosanol on the hepatic cholesterol biosynthesis of normocholesterolemic rats.
    Menendez R; Amor AM; Gonzalez RM; Fraga V; Mas R
    Biol Res; 1996; 29(2):253-7. PubMed ID: 9278716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Agents affecting lipid metabolism. XXXVI. Effect of N-cyclohexyl linoleamide on hepatic cholesterogenesis in vitro.
    Dvornik D
    Can J Biochem; 1968 Nov; 46(11):1430-2. PubMed ID: 5687076
    [No Abstract]   [Full Text] [Related]  

  • 26. Influence of procetofen on lipid metabolism in normocholesteremic rats.
    Kritchevsky D; Tepper SA; Story JA
    Pharmacol Res Commun; 1979 Sep; 11(8):635-41. PubMed ID: 515111
    [No Abstract]   [Full Text] [Related]  

  • 27. Effect of 2-acetoamidoethyl (p-chlorophenyl) (m-trifluoromethylphenoxy) acetate (halofenate) on cholesterol oxidation by rat liver mitochondria.
    Kritchevsky D; Tepper SA
    Proc Soc Exp Biol Med; 1972 Apr; 139(4):1284-7. PubMed ID: 5023326
    [No Abstract]   [Full Text] [Related]  

  • 28. Effect of clofibrate and 1-methyl-4-piperidyl bis (p-chlorophenoxy) acetate (Sandox 42-348) on steroid and drug metabolism by rat liver microsomes.
    Salvador RA; Haber S; Atkins C; Gommi BW; Welch RM
    Life Sci; 1970 Apr; 9(7):397-407. PubMed ID: 5445848
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of plasma cholesterol lowering agents on hepatobiliary lipid metabolism and cholesterol turnover in the rhesus monkey.
    Redinger RN; Passi RB
    Can J Physiol Pharmacol; 1979 Mar; 57(3):235-41. PubMed ID: 109175
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clofibrate, a peroxisome-proliferator, enhances reverse cholesterol transport through cytochrome P450 activation and oxysterol generation.
    Guan JZ; Tamasawa N; Murakami H; Matsui J; Yamato K; Suda T
    Tohoku J Exp Med; 2003 Dec; 201(4):251-9. PubMed ID: 14690017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolism of the hypolipidemic agent tiadenol in man and in the rat.
    Maffei Facino R; Carini M; Tofanetti O
    Arzneimittelforschung; 1986 Apr; 36(4):722-8. PubMed ID: 3718595
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of clofibrate on sterol metabolism in the rat.
    Cohen BI; Raicht RF; Shefer S; Mosbach EH
    Biochim Biophys Acta; 1974 Oct; 369(1):79-85. PubMed ID: 4418670
    [No Abstract]   [Full Text] [Related]  

  • 33. Studies on new nicotinic acid ester derivatives. VII. Effect of 2,2,6,6-tetrakisnicotinoyloxymethyl)cyclohexanol (K-31) on excretion and biosynthesis of cholesterol in rats.
    Kitagawa H; Higo K; Naruke T; Irikura T
    Chem Pharm Bull (Tokyo); 1971 Mar; 19(3):552-8. PubMed ID: 5553049
    [No Abstract]   [Full Text] [Related]  

  • 34. Some comparative effects of gemfibrozil, clofibrate, bezafibrate, cholestyramine and compactin on sterol metabolism in rats.
    Maxwell RE; Nawrocki JW; Uhlendorf PD
    Atherosclerosis; 1983 Sep; 48(3):195-203. PubMed ID: 6579963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of hypocholesteremic drugs on tumor-bearing mice.
    Kabara JJ; Chapman BB; Borin BM
    Proc Soc Exp Biol Med; 1972 Jan; 139(1):100-4. PubMed ID: 5007444
    [No Abstract]   [Full Text] [Related]  

  • 36. [Action of etofibrate, clofibrate and nicotinic acid on the metabolism of lipids in normolipemic rats. Short term effects and method of action].
    Priego JG; Piña M; Armijo M; Sunkel C; Maroto ML
    Arch Farmacol Toxicol; 1979 Apr; 5(1):29-42. PubMed ID: 38756
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of etofibrate, clofibrate and nicotinic acid on lipid metabolism in normolipemic rats.
    Priego JG; Maroto ML; Piña M; Catalan RE
    Gen Pharmacol; 1979; 10(3):215-9. PubMed ID: 467961
    [No Abstract]   [Full Text] [Related]  

  • 38. Fundamental studies on physiological and pharmacological actions of L-ascorbate 2-sulfate. I. On the hypolipidemic effects.
    Hayashi E; Yamada J; Kunitomo M; Terada M; Tomita T; Kinoshita
    J Nutr Sci Vitaminol (Tokyo); 1976; 22(3):201-8. PubMed ID: 966076
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hypocholesterolemic effect of 4,4'-(isopropylidenedithio)-bis(2,6-di-t-butylphenol) (probucol).
    Barnhart JW; Sefranka JA; McIntosh DD
    Am J Clin Nutr; 1970 Sep; 23(9):1229-33. PubMed ID: 5450842
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacological study of hydroxy bis-[2-(p-chlorophenoxy)-isobutyric acid] aluminium. II. The effect of hydroxy bis-[2-(-chlorophenoxy)-isobutyric acid] aluminum on lipid metabolism in hypercholesterolimic rats.
    Tomita T; Yamamura Y; Nagakura T; Hayashi E
    Jpn J Pharmacol; 1973 Jun; 23(3):289-98. PubMed ID: 4353343
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.